Best Life: GammaTile makes having surgery and radiation at the same time possible wmcactionnews5.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wmcactionnews5.com Daily Mail and Mail on Sunday newspapers.
Surgery for a cancerous brain tumor can be an overwhelming experience, and so too can the follow-up radiation therapy that can involve multiple trips back to the hospital and significant side effects.
Share this article
Share this article
PHILADELPHIA, Jan. 26, 2021 /PRNewswire/ Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with Glioblastoma Multiforme (GBM), today announced publication of Phase 1b clinical trial results in
Clinical Cancer Research, a journal of the American Association for Cancer Research. The article Phase1b Clinical Trial of IGV-001 for patients with Newly Diagnosed Glioblastoma is available online.
IGV-001 is a first-in-class personalized immunotherapy that uses the patient s own tumor cells combined with an antisense molecule to induce a potent immune response. The treatment comprises irradiated autologous glioma cells with an antisense oligodeoxynucleotide directed at the IGF-1R (Insulin-like Growth Factor type one Receptor) named IMV-001. Delivered through an implantable and removable bio-diffusion chamber, antigenic products are released and initiate both an innate and adaptive response.
Miami Cancer Institute appoints deputy director
Source/Disclosures Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Manmeet Ahluwalia, MD, FACP, MBA, has been appointed deputy director of Baptist Health’s Miami Cancer Institute.
Ahluwalia a neuro-oncologist whose research focuses on primary brain tumors and brain metastases also will serve as chief scientific officer and chief of solid tumor medical oncology.